Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization.

Zhi HY, Hou SW, Li RS, Basir Z, Xiang Q, Szabo A, Chen G.

Oncogene. 2011 Apr 7;30(14):1706-15. doi: 10.1038/onc.2010.543. Epub 2010 Nov 29.

PMID:
21119599
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.

Wietzke JA, Welsh J.

J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):149-57.

PMID:
12710998
[PubMed - indexed for MEDLINE]
3.

PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.

Hou SW, Zhi HY, Pohl N, Loesch M, Qi XM, Li RS, Basir Z, Chen G.

Cancer Res. 2010 Apr 1;70(7):2901-10. doi: 10.1158/0008-5472.CAN-09-3229. Epub 2010 Mar 23.

PMID:
20332238
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Resistance of HBL100 human breast epithelial cells to vitamin D action.

Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R.

Carcinogenesis. 1999 Apr;20(4):577-82.

PMID:
10223184
[PubMed - indexed for MEDLINE]
Free Article
5.

The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition.

Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J, DeLuca HF, Chen G.

J Biol Chem. 2002 Jul 19;277(29):25884-92. Epub 2002 Apr 30.

PMID:
11983707
[PubMed - indexed for MEDLINE]
Free Article
6.

Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.

Davoodi F, Brenner RV, Evans SR, Schumaker LM, Shabahang M, Nauta RJ, Buras RR.

J Steroid Biochem Mol Biol. 1995 Aug;54(3-4):147-53.

PMID:
7662588
[PubMed - indexed for MEDLINE]
7.

Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.

Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.

J Cell Physiol. 2001 Sep;188(3):383-93.

PMID:
11473365
[PubMed - indexed for MEDLINE]
8.

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. doi: 10.1186/bcr2230. Epub 2009 Feb 24.

PMID:
19239686
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.

Chang PL, Lee TF, Garretson K, Prince CW.

Clin Exp Metastasis. 1997 Nov;15(6):580-92.

PMID:
9344042
[PubMed - indexed for MEDLINE]
10.

Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.

Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL.

J Cell Biochem. 2004 Oct 1;93(2):384-97.

PMID:
15368364
[PubMed - indexed for MEDLINE]
11.

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Osborne JE, Hutchinson PE.

Br J Dermatol. 2002 Aug;147(2):197-213. Review.

PMID:
12174089
[PubMed - indexed for MEDLINE]
12.

Vitamin D receptors in breast cancer cells.

Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR.

Breast Cancer Res Treat. 1994;31(2-3):191-202.

PMID:
7881099
[PubMed - indexed for MEDLINE]
13.

Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.

Chen C, Zhou Z, Sheehan CE, Slodkowska E, Sheehan CB, Boguniewicz A, Ross JS.

Int J Cancer. 2009 Jun 15;124(12):2829-36. doi: 10.1002/ijc.24266.

PMID:
19267401
[PubMed - indexed for MEDLINE]
14.

Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.

Zhuang SH, Schwartz GG, Cameron D, Burnstein KL.

Mol Cell Endocrinol. 1997 Jan 3;126(1):83-90.

PMID:
9027366
[PubMed - indexed for MEDLINE]
15.

Expression of protein tyrosine phosphatases and its significance in esophageal cancer.

Warabi M, Nemoto T, Ohashi K, Kitagawa M, Hirokawa K.

Exp Mol Pathol. 2000 Jun;68(3):187-95. Erratum in: Exp Mol Pathol 2000 Oct;69(2):165.

PMID:
10816386
[PubMed - indexed for MEDLINE]
16.

Protein-tyrosine phosphatase H1 increases breast cancer sensitivity to antiestrogens by dephosphorylating estrogen receptor at Tyr537.

Suresh PS, Ma S, Migliaccio A, Chen G.

Mol Cancer Ther. 2014 Jan;13(1):230-8. doi: 10.1158/1535-7163.MCT-13-0610. Epub 2013 Nov 13.

PMID:
24227889
[PubMed - in process]
17.

Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.

Banwell CM, MacCartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O'Neill LP, Turner BM, Colston KW, Campbell MJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2004-13.

PMID:
16609009
[PubMed - indexed for MEDLINE]
Free Article
18.

The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.

Brenner RV, Shabahang M, Schumaker LM, Nauta RJ, Uskokovic MR, Evans SR, Buras RR.

Cancer Lett. 1995 May 25;92(1):77-82.

PMID:
7757962
[PubMed - indexed for MEDLINE]
19.

Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.

Nakopoulou L, Stefanaki K, Panayotopoulou E, Giannopoulou I, Athanassiadou P, Gakiopoulou-Givalou H, Louvrou A.

Hum Pathol. 2002 Sep;33(9):863-70.

PMID:
12378509
[PubMed - indexed for MEDLINE]
20.

Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL.

Cancer. 2009 Feb 15;115(4):899-908. doi: 10.1002/cncr.24103.

PMID:
19130459
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk